James C. Barrow

4.4k citations

68 papers · 2.4k indexed · h-index 29

Impact in

Organic Chemistry top 2%
- Synthetic Organic Chemistry Methods
- Asymmetric Synthesis and Catalysis
Cellular and Molecular Neuroscience top 5%
- Neuroscience and Neuropharmacology Research
- Neurotransmitter Receptor Influence on Behavior

Papers in

Cellular and Molecular Neuroscience 13
- Neuroscience and Neuropharmacology Research 9
- Neurotransmitter Receptor Influence on Behavior 6
Molecular Biology 37
- Chemical Synthesis and Analysis 7
- Ion channel regulation and function 7
- Protein Kinase Regulation and GTPase Signaling 6

Co-authors: Nicholas E. Calcaterra David A. Evans Peter W. Kalivas Philip E. Duffy B. Wesley Trotter Jeffrey L. Katz Timothy I. Richardson Michael R. Wood
Journals: Bioorganic & Medicinal Chemistry Letters (14 papers)Journal of Medicinal Chemistry (5 papers)ACS Medicinal Chemistry Letters (4 papers)Journal of the American Chemical Society (3 papers)Journal of Clinical Investigation (2 papers)
Partner nations: United States United Kingdom Finland

In The Last Decade

James C. Barrow

66 papers receiving 2.3k citations

Peers

Countries citing papers authored by James C. Barrow

Since Specialization

Citations

This map shows the geographic impact of James C. Barrow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James C. Barrow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James C. Barrow more than expected).

Fields of papers citing papers by James C. Barrow

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James C. Barrow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James C. Barrow. The network helps show where James C. Barrow may publish in the future.

Co-authorship network

The 25 scholars most cited alongside James C. Barrow, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with James C. Barrow Line = papers co-authored together James C. Barrow links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Development of a Novel Benzodiazepine to Delineate Peripheral GABA-A Signaling Mechanisms in Visceral Pain Syndromes Cellular and Molecular Gastroenterology and Hepatology ·Michael S. Poslusney, Ha Van Hoang, J B Lagrange, Yifang Huang, P. E. Taylor, Yaohui Zhu, Subhash Kulkarni, Gregory V. Carr, Henry Cuellar, Noelle White, Diane E. Peters, James C. Barrow, Pankaj J. Pasricha	2026	0
2	Ribosomal RNA transcription regulates splicing through ribosomal protein RPL22 Cell chemical biology ·Wenjun Fan, Hemalatha Mahansetty, Gregory C. Stachelek, Asma Begum, Angela J Carte, Youcai Yang, G Scatà, William C. Reinhold, Juan Manuel Estrada Jiménez, Qizhi Zheng, Angelo M. De Marzo, N.V. Rajeshkumar, James C. Barrow, Moritz Seebacher	2025	1
3	The IP6K Inhibitor LI-2242 Ameliorates Diet-Induced Obesity, Hyperglycemia, and Hepatic Steatosis in Mice by Improving Cell Metabolism and Insulin Signaling Biomolecules ·Guido Aliaga-Pichihua, Molee Chakraborty, G. Donatuti, G Scatà, Michael DePasquale, Danielle Carpenter, James C. Barrow, Anutosh Chakraborty	2023	8
4	Identification of Small-Molecule Inhibitors of Human Inositol Hexakisphosphate Kinases by High-Throughput Screening ACS Pharmacology & Translational Science ·Gangling Liao, Wenjuan Ye, M. Enea, G Scatà, Michael DePasquale, Yujing Tang, Jordan C. Komisarow, Xin Hu, Marc Ferrer, Robert K. Harmel, Dorothea Fiedler, James C. Barrow, Huijun Wei	2021	24
5	Inhibition of Catechol-O-methyltransferase Does Not Alter Effort-Related Choice Behavior in a Fixed Ratio/Concurrent Chow Task in Male Mice Frontiers in Behavioral Neuroscience ·Henry Cuellar, Dominique Legand, James C. Barrow, Gregory V. Carr	2020	8
6	Synthesis and characterization of novel isoform-selective IP6K1 inhibitors Bioorganic & Medicinal Chemistry Letters ·Jordan C. Komisarow, G Scatà, Huijun Wei, James C. Barrow	2019	15
7	Novel inhibitors of As(III) S-adenosylmethionine methyltransferase (AS3MT) identified by virtual screening Bioorganic & Medicinal Chemistry Letters ·Roland W. Bürli, Huijun Wei, G Scatà, Abigail Mariga, M Mischlisch, Kara Herlihy, A.J. Cross, Steven S. Wesolowski, Hongming Chen, Ronald D.G. McKay, Daniel R. Weinberger, Nicholas J. Brandon, James C. Barrow	2018	7
8	Development of a homogenous high-throughput assay for inositol hexakisphosphate kinase 1 activity PLoS ONE ·Jordan C. Komisarow, Gangling Liao, Martha Kimos, James C. Barrow, Huijun Wei	2017	18
9	TNP [N2-(m-Trifluorobenzyl), N6-(p-nitrobenzyl)purine] ameliorates diet induced obesity and insulin resistance via inhibition of the IP6K1 pathway Molecular Metabolism ·S. P. Ghoshal, Qingzhang Zhu, Alice Asteian, Hua Lin, Haifei Xu, G Scatà, James C. Barrow, Baoji Xu, Michael D. Cameron, Theodore M. Kamenecka, Anutosh Chakraborty	2016	47
10	Inositol pyrophosphates promote tumor growth and metastasis by antagonizing liver kinase B1 Proceedings of the National Academy of Sciences ·Feng Rao, Jing Xu, Chenglai Fu, Y. Jiyoung, Moataz M. Gadalla, Risheng Xu, James C. Barrow, Solomon H. Snyder	2015	78
11	Development of an HTRF Assay for the Detection and Characterization of Inhibitors of Catechol-O-Methyltransferase SLAS DISCOVERY ·Martha Kimos, Maggi Burton, Juan P. OROZCO, D. Kohl, В В Надьон, M. Widelicki, Michel Gillard, James C. Barrow, Martyn Wood	2015	11
12	Inhibitors of Catechol-O-Methyltransferase CNS & Neurological Disorders - Drug Targets ·James C. Barrow	2012	11
13	High concentration electrophysiology-based fragment screen: Discovery of novel acid-sensing ion channel 3 (ASIC3) inhibitors Bioorganic & Medicinal Chemistry Letters ·S. E. Wolkenberg, Zhijian Zhao, Eva-Maria Herring, Scott T. Harrison, John M. Sanders, Matthew J. Cato, Aneta Jovanovska, R Innamorati, Sean P. Cook, Darrell A. Henze, Stefanie A. Kane, George D. Hartman, James C. Barrow	2010	17
14	Antagonism of T-type calcium channels inhibits high-fat diet–induced weight gain in mice Journal of Clinical Investigation ·Victor N. Uebele, Anthony L. Gotter, Cindy E. Nuss, Richard L. Kraus, Scott M. Doran, Susan L. Garson, Duane R. Reiss, Yuxing Li, James C. Barrow, Thomas S. Reger, Zhi-Qiang Yang, Jeanine Ballard, Cuyue Tang, Joseph M. Metzger, J Pilitisis, Kenneth S. Koblan, John J. Renger	2009	61
15	Unexpected enhancement of thrombin inhibitor potency with o-aminoalkylbenzylamides in the P1 position Bioorganic & Medicinal Chemistry Letters ·Kenneth E. Rittle, James C. Barrow, Fredrick Oporia, Sameer Dubey, Julie A. Krueger, Lawrence C. Kuo, Sidney D. Lewis, Bobby J. Lucas, Daniel R. McMasters, Vuk Markovic, Philippe G. Nantermet, Katherine Elizabeth Bampton, William M. Sanders, Youwei Yan, Joseph P. Vacca, Harold G. Selnick	2003	20
16	Synthesis and Evaluation of Imidazole Acetic Acid Inhibitors of Activated Thrombin-Activatable Fibrinolysis Inhibitor as Novel Antithrombotics Journal of Medicinal Chemistry ·James C. Barrow, Philippe G. Nantermet, Shaun R. Stauffer, Kazuyoshi Masaki, Subur Binyati, Shi‐Shan Mao, Steven S. Carroll, Octy Wijayanti, Dennis Colussi, 李在徹, Christine Burlein, Jacquelynn J. Cook, Gary R. Sitko, Philip R. Tiller, Cynthia Miller‐Stein, Mark J. Rose, Daniel R. McMasters, Joseph P. Vacca, Harold G. Selnick	2003	36
17	Preparation and evaluation of 1,3-diaminocyclopentane-linked dihydropyrimidinone derivatives as selective α1a-receptor antagonists Bioorganic & Medicinal Chemistry Letters ·James C. Barrow, Sameer Dubey, Harold G. Selnick, Roger Freidinger, Raymond S.L. Chang, Stacey O’Malley, L L Mojzhes	2000	20
18	Selective α1a adrenergic receptor antagonists based on 4-aryl-3,4-dihydropyridine-2-ones Bioorganic & Medicinal Chemistry Letters ·Philippe G. Nantermet, James C. Barrow, Harold G. Selnick, Carl F. Homnick, Roger Freidinger, Raymond S.L. Chang, Stacey O’Malley, Duane R. Reiss, Theodore P. Broten, Richard W. Ransom, Douglas J. Pettibone, Timothy Olah, Carlos Forray	2000	44
19	Total Syntheses of Vancomycin and Eremomycin Aglycons Angewandte Chemie International Edition ·David A. Evans, Michael R. Wood, B. Wesley Trotter, Timothy I. Richardson, James C. Barrow, Jeffrey L. Katz	1998	214
20	Regulation of the mesocorticolimbic dopamine system by glutamic acid receptor subtypes. Journal of Pharmacology and Experimental Therapeutics ·Peter W. Kalivas, Philip E. Duffy, James C. Barrow	1989	195

About James C. Barrow

James C. Barrow is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology, Hematology, Cell Biology and Pharmacology, having authored 68 papers that have together received 2.4k indexed citations. Recurring topics across this work include Neuroscience and Neuropharmacology Research (9 papers), Chemical Synthesis and Analysis (7 papers), Ion channel regulation and function (7 papers), Protein Kinase Regulation and GTPase Signaling (6 papers), Blood Coagulation and Thrombosis Mechanisms (6 papers), Neurotransmitter Receptor Influence on Behavior (6 papers), Endoplasmic Reticulum Stress and Disease (6 papers) and Cardiac electrophysiology and arrhythmias (5 papers). The work is most often cited by research in Organic Chemistry (823 citations), Cellular and Molecular Neuroscience (429 citations), Pharmacology (302 citations), Molecular Biology (1.2k citations) and Cell Biology (207 citations). James C. Barrow has collaborated with scholars based in United States, United Kingdom and Finland. Frequent co-authors include Nicholas E. Calcaterra, David A. Evans, Peter W. Kalivas, Philip E. Duffy, B. Wesley Trotter, Jeffrey L. Katz, Timothy I. Richardson, Michael R. Wood, Harold G. Selnick and Philippe G. Nantermet. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Journal of Medicinal Chemistry, ACS Medicinal Chemistry Letters, Journal of the American Chemical Society and Journal of Clinical Investigation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact